184 related articles for article (PubMed ID: 26240053)
1. Nano-Based Anti-Tubercular Drug Delivery and Therapeutic Interventions in Tuberculosis.
Sharma R; Kaur A; Sharma AK; Dilbaghi N; Sharma AK
Curr Drug Targets; 2017; 18(1):72-86. PubMed ID: 26240053
[TBL] [Abstract][Full Text] [Related]
2. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
3. Advances in nanotechnology-based carrier systems for targeted delivery of bioactive drug molecules with special emphasis on immunotherapy in drug resistant tuberculosis - a critical review.
Singh J; Garg T; Rath G; Goyal AK
Drug Deliv; 2016 Jun; 23(5):1676-98. PubMed ID: 26289212
[TBL] [Abstract][Full Text] [Related]
4. Nano-carriers for the Treatment of Tuberculosis.
Gilani SJ; Ameeduzzafar ; Jafar M; Shakil K; Imam SS
Recent Pat Antiinfect Drug Discov; 2017; 12(2):95-106. PubMed ID: 28595544
[TBL] [Abstract][Full Text] [Related]
5. Nano-based anti-tubercular drug delivery: an emerging paradigm for improved therapeutic intervention.
Nabi B; Rehman S; Aggarwal S; Baboota S; Ali J
Drug Deliv Transl Res; 2020 Aug; 10(4):1111-1121. PubMed ID: 32418158
[TBL] [Abstract][Full Text] [Related]
6. Nanotechnology in Tuberculosis: State of the Art and the Challenges Ahead.
Grotz E; Tateosian N; Amiano N; Cagel M; Bernabeu E; Chiappetta DA; Moretton MA
Pharm Res; 2018 Sep; 35(11):213. PubMed ID: 30238168
[TBL] [Abstract][Full Text] [Related]
7. Current therapeutic delivery approaches using nanocarriers for the treatment of tuberculosis disease.
Biswas B; Misra TK; Ray D; Majumder T; Bandyopadhyay TK; Bhowmick TK
Int J Pharm; 2023 Jun; 640():123018. PubMed ID: 37149113
[TBL] [Abstract][Full Text] [Related]
8. Exploring inhalable polymeric dry powders for anti-tuberculosis drug delivery.
Miranda MS; Rodrigues MT; Domingues RMA; Torrado E; Reis RL; Pedrosa J; Gomes ME
Mater Sci Eng C Mater Biol Appl; 2018 Dec; 93():1090-1103. PubMed ID: 30274040
[TBL] [Abstract][Full Text] [Related]
9. Current Approaches and Future Prospects of Nanomedicine in Tuberculosis Therapy.
Athar MT; Ullah Z
Recent Pat Antiinfect Drug Discov; 2017; 12(2):120-127. PubMed ID: 28443511
[TBL] [Abstract][Full Text] [Related]
10. Drug targets exploited in Mycobacterium tuberculosis: Pitfalls and promises on the horizon.
Bhat ZS; Rather MA; Maqbool M; Ahmad Z
Biomed Pharmacother; 2018 Jul; 103():1733-1747. PubMed ID: 29864964
[TBL] [Abstract][Full Text] [Related]
11. Nanostructured Therapeutic Carriers for Tuberculosis Treatment: Approaches & Challenges.
Ullah Z; Athar MT; Samad A
Recent Pat Antiinfect Drug Discov; 2017; 12(2):128-137. PubMed ID: 28990537
[TBL] [Abstract][Full Text] [Related]
12. Liposomes as drug delivery systems for the treatment of TB.
Pinheiro M; Lúcio M; Lima JL; Reis S
Nanomedicine (Lond); 2011 Oct; 6(8):1413-28. PubMed ID: 22026379
[TBL] [Abstract][Full Text] [Related]
13. Nanoemulsion for the Effective Treatment and Management of Anti-tubercular Drug Therapy.
Beg S; Saini S; Imam SS; Rahman M; Swain S; Hasnain MS
Recent Pat Antiinfect Drug Discov; 2017; 12(2):85-94. PubMed ID: 28480833
[TBL] [Abstract][Full Text] [Related]
14. The formulation of nanomedicines for treating tuberculosis.
Costa A; Pinheiro M; Magalhães J; Ribeiro R; Seabra V; Reis S; Sarmento B
Adv Drug Deliv Rev; 2016 Jul; 102():102-15. PubMed ID: 27108703
[TBL] [Abstract][Full Text] [Related]
15. Macrophage Targeted Cellular Carriers for Effective Delivery of Anti-Tubercular Drugs.
Agnihotri J; Singh S; Wais M; Pathak A
Recent Pat Antiinfect Drug Discov; 2017; 12(2):162-183. PubMed ID: 29219058
[TBL] [Abstract][Full Text] [Related]
16. Advanced drug delivery and therapeutic strategies for tuberculosis treatment.
Nair A; Greeny A; Nandan A; Sah RK; Jose A; Dyawanapelly S; Junnuthula V; K V A; Sadanandan P
J Nanobiotechnology; 2023 Nov; 21(1):414. PubMed ID: 37946240
[TBL] [Abstract][Full Text] [Related]
17. Nanoemulsion-Based Transdermal Drug Delivery System for the Treatment of Tuberculosis.
Wais M; Aqil M; Goswami P; Agnihotri J; Nadeem S
Recent Pat Antiinfect Drug Discov; 2017; 12(2):107-119. PubMed ID: 28571549
[TBL] [Abstract][Full Text] [Related]
18. Current nanotechnological strategies for effective delivery of bioactive drug molecules in the treatment of tuberculosis.
Kaur M; Garg T; Rath G; Goyal AK
Crit Rev Ther Drug Carrier Syst; 2014; 31(1):49-88. PubMed ID: 24579767
[TBL] [Abstract][Full Text] [Related]
19. The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis.
Gelperina S; Kisich K; Iseman MD; Heifets L
Am J Respir Crit Care Med; 2005 Dec; 172(12):1487-90. PubMed ID: 16151040
[TBL] [Abstract][Full Text] [Related]
20. Current Nanotechnological Approaches for an Effective Delivery of Bioactive Drug Molecules to Overcome Drug Resistance Tuberculosis.
Garg T; Rath G; Murthy RR; Gupta UD; Vatsala PG; Goyal AK
Curr Pharm Des; 2015; 21(22):3076-89. PubMed ID: 26027577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]